Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

• Last SEC data release: 2025-12-31
• Last 15 days FTD volume: HK$0.19 M
• Last 3 months FTD volume: HK$4.79 M
• Last 12 months FTD volume: HK$10.83 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Ultragenyx Pharmaceutical RARE	HK$4.26 M	HK$10.15 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	HK$7.78 M	HK$13.12 M	🇺🇸 USA
Pfizer PFE	HK$55.69 M	HK$0.12 B	🇺🇸 USA
Regeneron Pharmaceuticals REGN	HK$4.51 M	HK$69.96 M	🇺🇸 USA
Amicus Therapeutics FOLD	HK$8.5 M	HK$17.89 M	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	HK$1.51 M	HK$12.46 M	🇺🇸 USA